Wall Street brokerages forecast that Alcentra Capital Corp. (NASDAQ:ABDC) will announce sales of $8.91 million for the current quarter, according to Zacks. Five analysts have provided estimates for Alcentra Capital Corp.’s earnings. The lowest sales estimate is $8.40 million and the highest is $9.35 million. Alcentra Capital Corp. reported sales of $9.12 million in the same quarter last year, which would suggest a negative year-over-year growth rate of 2.3%. The company is scheduled to report its next quarterly earnings report on Thursday, November 2nd.

On average, analysts expect that Alcentra Capital Corp. will report full year sales of $8.91 million for the current financial year, with estimates ranging from $34.95 million to $37.19 million. For the next fiscal year, analysts anticipate that the company will report sales of $38.87 million per share, with estimates ranging from $36.58 million to $40.12 million. Zacks’ sales averages are an average based on a survey of sell-side analysts that that provide coverage for Alcentra Capital Corp..

ABDC has been the topic of a number of recent research reports. Keefe, Bruyette & Woods set a $13.00 price objective on Alcentra Capital Corp. and gave the company a “hold” rating in a report on Sunday, August 6th. DA Davidson assumed coverage on Alcentra Capital Corp. in a report on Wednesday, July 5th. They set a “buy” rating and a $15.00 price objective on the stock. TheStreet downgraded Alcentra Capital Corp. from a “b” rating to a “c+” rating in a report on Monday, July 24th. ValuEngine raised Alcentra Capital Corp. from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Finally, Raymond James Financial, Inc. downgraded Alcentra Capital Corp. from a “strong-buy” rating to an “outperform” rating and reduced their target price for the stock from $16.00 to $14.00 in a report on Monday, July 17th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $13.50.

In other Alcentra Capital Corp. news, Director Steven H. Reiff bought 11,668 shares of the company’s stock in a transaction on Monday, August 7th. The stock was bought at an average price of $10.72 per share, for a total transaction of $125,080.96. Following the transaction, the director now owns 7,000 shares of the company’s stock, valued at approximately $75,040. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 4.96% of the company’s stock.

Several institutional investors have recently modified their holdings of the business. Oppenheimer & Co. Inc. raised its position in shares of Alcentra Capital Corp. by 4.4% during the 2nd quarter. Oppenheimer & Co. Inc. now owns 13,098 shares of the asset manager’s stock valued at $178,000 after acquiring an additional 550 shares during the last quarter. Wells Fargo & Company MN raised its position in shares of Alcentra Capital Corp. by 4.9% during the 1st quarter. Wells Fargo & Company MN now owns 28,835 shares of the asset manager’s stock valued at $396,000 after acquiring an additional 1,354 shares during the last quarter. Carnegie Capital Asset Management LLC increased its position in shares of Alcentra Capital Corp. by 8.1% in the 2nd quarter. Carnegie Capital Asset Management LLC now owns 20,011 shares of the asset manager’s stock valued at $232,000 after buying an additional 1,500 shares in the last quarter. Confluence Investment Management LLC increased its position in shares of Alcentra Capital Corp. by 2.7% in the 2nd quarter. Confluence Investment Management LLC now owns 209,528 shares of the asset manager’s stock valued at $2,847,000 after buying an additional 5,566 shares in the last quarter. Finally, Royal Bank of Canada increased its position in shares of Alcentra Capital Corp. by 1,948.4% in the 2nd quarter. Royal Bank of Canada now owns 8,808 shares of the asset manager’s stock valued at $120,000 after buying an additional 8,378 shares in the last quarter. Institutional investors own 31.81% of the company’s stock.

Shares of Alcentra Capital Corp. (ABDC) traded down 0.8762% during trading on Thursday, reaching $10.0115. The company had a trading volume of 2,345 shares. Alcentra Capital Corp. has a 52 week low of $9.93 and a 52 week high of $14.73. The firm has a 50-day moving average of $10.63 and a 200 day moving average of $12.27.

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 5th. Shareholders of record on Saturday, September 30th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 13.47%. The ex-dividend date of this dividend was Thursday, September 28th. Alcentra Capital Corp.’s payout ratio is -1,700.00%.

TRADEMARK VIOLATION NOTICE: “$8.91 Million in Sales Expected for Alcentra Capital Corp. (ABDC) This Quarter” was first posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://www.americanbankingnews.com/2017/10/26/8-91-million-in-sales-expected-for-alcentra-capital-corp-abdc-this-quarter-2.html.

Alcentra Capital Corp. Company Profile

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Get a free copy of the Zacks research report on Alcentra Capital Corp. (ABDC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Alcentra Capital Corp. (NASDAQ:ABDC)

Receive News & Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related companies with MarketBeat.com's FREE daily email newsletter.